Atlas Trials

Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma

Clinical trial NCT03188354 · COMPLETED

Trial details

NCT number
NCT03188354
Sponsor
Norwegian University of Science and Technology
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma, Non-HodgkinCentral Nervous System Neoplasms
Start date
2017-11-01
Primary completion
2023-12-31
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.